Clinical Immunology, Endocrine & Metabolic
Drugs publishes original research, expert
reviews, drug clinical trials and thematic issues in all
core areas of translational and clinical immunology, endocrine
& metabolic drug research.
The journal publishes pre-clinical and clinical studies
on the development of new immunology, endocrine & metabolic
agents. Clinical studies of new reported immunology, endocrine
& metabolic drugs include Phase 1 - IV clinical trial studies,
their designs, research methodologies, and analyses. The
journal is essential reading to clinicians, toxicologists,
medicinal chemists, and pharmacologists.